Consensus statement for the treatment of infantile haemangiomas with propranolol

被引:60
作者
Smithson, Sarah L. [1 ]
Rademaker, Marius [2 ]
Adams, Susan [3 ]
Bade, Stuart [4 ]
Bekhor, Philip [1 ]
Davidson, Samantha [4 ]
Dore, Amanda [4 ]
Drummond, Catherine [5 ]
Fischer, Gayle [6 ]
Gin, Alexander [1 ]
Grills, Claire [1 ]
Halbert, Anne [7 ]
Lokmic, Zerina [8 ]
McCahon, Emma [9 ]
Morgan, Vanessa A. [1 ]
Murrell, Dedee F. [10 ]
Orchard, David [1 ]
Penington, Anthony [1 ]
Purvis, Diana [11 ]
Relic, John [12 ]
Robertson, Susan [1 ]
Robinson, Aaron J. [1 ]
Scardamaglia, Laura [1 ]
Su, John [1 ]
Tan, Swee [13 ]
Wargon, Orli [14 ]
Warren, Lachlan [15 ]
Wong, Li-chuen [9 ]
Zappala, Tania [4 ]
Phillips, Roderic [1 ]
机构
[1] Royal Childrens Hosp, 50 Flemington Rd, Melbourne, Vic 3052, Australia
[2] Waikato Hosp, Hamilton, New Zealand
[3] Univ New South Wales, Sch Womens & Childrens Hlth, Randwick, NSW, Australia
[4] Lady Cilentro Childrens Hosp, Brisbane, Qld, Australia
[5] Canberra Hosp, Canberra, ACT, Australia
[6] Univ Sydney, Sydney, NSW, Australia
[7] Princess Margaret Hosp Children, Perth, WA, Australia
[8] Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[9] Childrens Hosp Westmead, Sydney, NSW, Australia
[10] St George Hosp Campus, Sydney, NSW, Australia
[11] Starship Childrens Hosp, Auckland, New Zealand
[12] John Hunter Childrens Hosp, Newcastle, NSW, Australia
[13] Gillies McIndoe Res Inst, Wellington, New Zealand
[14] Sydney Childrens Hosp, Sydney, NSW, Australia
[15] Womens & Childrens Hosp, Adelaide, SA, Australia
关键词
Australian; beta-blocker; consensus; hemangioma; infantile haemangioma; New Zealand; propranolol; vascular anomaly; CONTROLLED-TRIAL; THERAPY; INFANCY;
D O I
10.1111/ajd.12600
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Although most infantile haemangiomas do not require treatment due to a natural history of spontaneous involution, some require early intervention. The Australasian Vascular Anomalies Network and the Australasian Paediatric Dermatology Network have developed a consensus statement for the treatment of infantile haemangiomas with oral propranolol. Infants with haemangiomas that are life threatening, at risk of ulceration, or at risk of causing a significant functional impairment, psychological impact or physical deformity should be treated early with oral propranolol. Oral propranolol is safe and effective and in most healthy infants oral propranolol can be started in an outpatient setting.
引用
收藏
页码:155 / 159
页数:5
相关论文
共 22 条
[1]   Hemangiomas of infancy [J].
Bruckner, AL ;
Frieden, IJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (04) :477-493
[2]   SUCCESSFUL TREATMENT OF JUVENILE HEMANGIOMAS WITH PREDNISONE [J].
FOST, NC ;
ESTERLY, NB .
JOURNAL OF PEDIATRICS, 1968, 72 (03) :351-+
[3]  
Frieden IJ, 2009, J DERMATOL, V50, P69
[4]   Conditions masquerading as infantile haemangioma: Part 2 [J].
Frieden, Ilona J. ;
Rogers, Maureen ;
Garzon, Maria C. .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2009, 50 (03) :153-170
[5]   Conditions masquerading as infantile haemangioma: Part 1 [J].
Frieden, Ilona J. ;
Rogers, Maureen ;
Garzon, Maria C. .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2009, 50 (02) :77-99
[6]   A Randomized Controlled Trial of Propranolol for Infantile Hemangiomas [J].
Hogeling, Marcia ;
Adams, Susan ;
Wargon, Orli .
PEDIATRICS, 2011, 128 (02) :E259-E266
[7]   The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action [J].
Ji, Y. ;
Chen, S. ;
Xu, C. ;
Li, L. ;
Xiang, B. .
BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (01) :24-32
[8]   Risk of neurodevelopmental abnormalities in children treated with propranolol [J].
Labreze, C. ;
Voisard, J. -J. ;
Delarue, A. ;
Moore, N. .
BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (06) :1562-1564
[9]   Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas [J].
Langley, A. ;
Pope, E. .
BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (01) :13-23
[10]   A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma [J].
Leaute-Labreze, C. ;
Hoeger, P. ;
Mazereeuw-Hautier, J. ;
Guibaud, L. ;
Baselga, E. ;
Posiunas, G. ;
Phillips, R. J. ;
Caceres, H. ;
Lopez Gutierrez, J. C. ;
Ballona, R. ;
Friedlander, S. F. ;
Powell, J. ;
Perek, D. ;
Metz, B. ;
Barbarot, S. ;
Maruani, A. ;
Szalai, Z. Z. ;
Krol, A. ;
Boccara, O. ;
Foelster-Holst, R. ;
Febrer Bosch, M. I. ;
Su, J. ;
Buckova, H. ;
Torrelo, A. ;
Cambazard, F. ;
Grantzow, R. ;
Wargon, O. ;
Wyrzykowski, D. ;
Roessler, J. ;
Bernabeu-Wittel, J. ;
Valencia, A. M. ;
Przewratil, P. ;
Glick, S. ;
Pope, E. ;
Birchall, N. ;
Benjamin, L. ;
Mancini, A. J. ;
Vabres, P. ;
Souteyrand, P. ;
Frieden, I. J. ;
Berul, C. I. ;
Mehta, C. R. ;
Prey, S. ;
Boralevi, F. ;
Morgan, C. C. ;
Heritier, S. ;
Delarue, A. ;
Voisard, J-J .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (08) :735-746